Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William DuMouchel

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Investigative Radiology|July 11, 2006
Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effectsRichard Solomon, William Dumouchel
Expert Opinion on Drug Safety|August 11, 2007
Signal detection methodologies to support effective safety managementRobbert P van Manen, David Fram, William DuMouchel
Drug Safety|October 30, 2013
Evaluation of disproportionality safety signaling applied to healthcare databasesWilliam DuMouchel, Patrick B Ryan, Martijn J Schuemie, et al.
Journal of Biopharmaceutical Statistics|January 22, 2013
Automated method for detecting increases in frequency of spontaneous adverse event reports over timeWilliam DuMouchel, Nancy Yuen, Nassrin Payvandi, et al.
Drug Safety|September 15, 2006
Comparative performance of two quantitative safety signalling methods: implications for use in a pharmacovigilance departmentJune S Almenoff, Karol K LaCroix, Nancy A Yuen, et al.
Statistics in Medicine|August 1, 2013
Interpreting observational studies: why empirical calibration is needed to correct p-valuesMartijn J Schuemie, Patrick B Ryan, William DuMouchel, et al.
Elife|August 9, 2017
Reverse translation of adverse event reports paves the way for de-risking preclinical off-targetsMateusz Maciejewski, Eugen Lounkine, Steven Whitebread, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|February 26, 2008
Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004)William DuMouchel, David Fram, Xionghu Yang, et al.
Clinical Therapeutics|September 1, 2004
Association of asthma therapy and Churg-Strauss syndrome: an analysis of postmarketing surveillance dataWilliam DuMouchel, Eric T Smith, Richard Beasley, et al.
Journal of Biomedical Informatics|November 28, 2015
Early identification of adverse drug reactions from search log dataRyen W White, Sheng Wang, Apurv Pant, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Investigative Radiology|July 11, 2006
Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effectsRichard Solomon, William Dumouchel
Expert Opinion on Drug Safety|August 11, 2007
Signal detection methodologies to support effective safety managementRobbert P van Manen, David Fram, William DuMouchel
Drug Safety|October 30, 2013
Evaluation of disproportionality safety signaling applied to healthcare databasesWilliam DuMouchel, Patrick B Ryan, Martijn J Schuemie, et al.
Journal of Biopharmaceutical Statistics|January 22, 2013
Automated method for detecting increases in frequency of spontaneous adverse event reports over timeWilliam DuMouchel, Nancy Yuen, Nassrin Payvandi, et al.
Drug Safety|September 15, 2006
Comparative performance of two quantitative safety signalling methods: implications for use in a pharmacovigilance departmentJune S Almenoff, Karol K LaCroix, Nancy A Yuen, et al.
Statistics in Medicine|August 1, 2013
Interpreting observational studies: why empirical calibration is needed to correct p-valuesMartijn J Schuemie, Patrick B Ryan, William DuMouchel, et al.
Elife|August 9, 2017
Reverse translation of adverse event reports paves the way for de-risking preclinical off-targetsMateusz Maciejewski, Eugen Lounkine, Steven Whitebread, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|February 26, 2008
Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004)William DuMouchel, David Fram, Xionghu Yang, et al.
Clinical Therapeutics|September 1, 2004
Association of asthma therapy and Churg-Strauss syndrome: an analysis of postmarketing surveillance dataWilliam DuMouchel, Eric T Smith, Richard Beasley, et al.
Journal of Biomedical Informatics|November 28, 2015
Early identification of adverse drug reactions from search log dataRyen W White, Sheng Wang, Apurv Pant, et al.
Pageof 2